Adams “edible film” OTCs

Executive Summary

Adams Respiratory Therapeutics will develop oral thin-film drug delivery OTC and pharmaceutical respiratory products under a licensing agreement with drug delivery firm MonoSol Rx, the company announces March 27. Under the deal, Adams receives an exclusive, royalty-bearing non-transferable license from MonoSol to develop and market two or more respiratory products in North America. Under a separate agreement, MonoSol will manufacture and supply the finished products. MonoSol will complete product development, while Adams will perform all clinical development, regulatory submissions and commercial operations. Financial terms of the deal were not disclosed, but Adams notes MonoSol will receive payments in exchange for completing pre-defined development milestones. Leiner launched several OTC drug and dietary supplement products in orally dissolving strips in 2005 under a deal with MonoSol (1"The Tan Sheet" Aug. 15, 2005, p. 8)...